Cabozantinib in Advanced Solid Malignancies

Clinical trial NCT01588821 · COMPLETED

Trial details

NCT number: NCT01588821
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Solid Tumor (Not Breast or Prostate Cancers)

Start date: 2012-06-01
Primary completion: 2017-01-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.